Georgia Capital PLC (BST:2IX)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.50B +76.4% |
| Revenue (ttm) | 545.06M +6.2% |
| Net Income | 541.70M +5.9% |
| EPS | 16.13 +17.2% |
| Shares Out | n/a |
| PE Ratio | 2.78 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 51.00 |
| Previous Close | 51.00 |
| Day's Range | 50.50 - 51.50 |
| 52-Week Range | 26.60 - 58.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |
About Georgia Capital
Georgia Capital PLC is a private equity and venture capital firm specializing in early stage, organic growth and acquisitions. It considers Greenfields through mature stage companies. The firm typically invests in automotive retail, education services, hotels, resorts & cruise lines, restaurants, beverages, healthcare, banks, property and casualty insurance, life and health insurance, diversified REITs, water utilities, and renewable electricity. It seeks to invest in Georgia. The firm seeks board position in public portfolio companies. It exit... [Read more]
Financial Performance
In 2025, Georgia Capital's revenue was 1.90 billion, an increase of 415.81% compared to the previous year's 368.10 million. Earnings were 1.89 billion, an increase of 422.43%.
Financial numbers in GEL Financial StatementsNews
Georgia Capital H1 Earnings Call Highlights
Georgia Capital LON: CGEO reported strong first-half 2026 operating momentum across its private portfolio, with net asset value per share rising 13% in the first quarter and aggregate portfolio-compan...
Georgia Capital Earnings Call Transcript: H1 2026
NAV rose 13% in Q2, driven by strong portfolio company performance and Lion Finance Group gains. Leverage reduced to zero at holdco, with robust revenue and EBITDA growth across Pharmacy, Healthcare, and Insurance segments. GEL 1 billion capital allocation program launched for buybacks, dividends, and investments.
Georgia Capital Quarterly report: H1 2026
Georgia Capital has published its H1 2026 quarterly earnings report on August 4, 2026.
Georgia Capital Slides: H1 2026
Georgia Capital has posted slides in relation to its H1 2026 quarterly earnings report, which was published on August 4, 2026.
Georgia Capital Slides: Investor presentation
Georgia Capital has posted slides in relation to its latest quarterly earnings report, which was published on August 4, 2026.
Georgia Capital Earnings Call Transcript: Q1 2026
NAV per share grew over 9% YTD, driven by strong portfolio company results and buybacks. Retail Pharmacy, Healthcare, and Insurance segments all posted double-digit revenue and EBITDA growth, while capital return and expansion in Armenia remain strategic priorities.
Georgia Capital Slides: Q1 2026
Georgia Capital has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 28, 2026.
Georgia Capital Quarterly report: Q1 2026
Georgia Capital has published its Q1 2026 quarterly earnings report on April 28, 2026.
Georgia Capital Slides: Investor presentation
Georgia Capital has posted slides in relation to its latest quarterly earnings report, which was published on April 28, 2026.
Georgia Capital Earnings Call Transcript: H2 2025
EV per share rose 14.1% in Q4 and 61% for the year, driven by strong portfolio and macroeconomic performance. Capital return program is ahead of schedule, with 80% completed, and key segments—retail pharmacy, insurance, and healthcare—delivered double-digit growth and robust cash flow.
Georgia Capital Annual report: H2 2025
Georgia Capital has published its H2 2025 annual report on February 24, 2026.
Georgia Capital Slides: H2 2025
Georgia Capital has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 24, 2026.
Georgia Capital Annual report: H2 2025
Georgia Capital has published its H2 2025 annual report on February 24, 2026.
Georgia Capital Slides: Investor presentation
Georgia Capital has posted slides in relation to its latest quarterly earnings report, which was published on February 24, 2026.
Georgia Capital Earnings Call Transcript: Q3 2025
NAV per share rose nearly 8% in Q3, driven by strong portfolio company performance and share buybacks. Retail pharmacy, insurance, and healthcare segments all posted double-digit revenue and EBITDA growth, with robust cash flow and dividend outlook. Capital return and buyback programs are ahead of schedule.
Georgia Capital Quarterly report: Q3 2025
Georgia Capital has published its Q3 2025 quarterly earnings report on October 27, 2025.
Georgia Capital Slides: Q3 2025
Georgia Capital has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 27, 2025.